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ABSTRACT 
Indirect evidence (Blaber. 1963) has .uouted that facUttatoIT 
drug. mal' potenUa,. the mUlcte twitch and anta,oni.e tubocurariae without 
lDbibttln, aceVlcholilleatera •• (AChE). 1ft the pre •• nt .tuq th. bldir.ct17 
sUmulated cat anterior tibla11. mu.ct. wu -eel; dr'up w .... lajeeted clo.e 
arteriaUy (5 microlftml. aad iIltraveD~ (JIO microFilm.). A t the 
het.t of the facilltatol7 effect. DW was irQecteci intravellCJ\laq ill doa .. 
wbich completel, iDblbited ACbB tn c_trot .. erimeng. The femoral 
artel')' and vela were •• aeqaentl7ltpted. Oae hour later, the mu.cle 
wu removed ud .tafAed for ACd Uln, the ltoeU. teelmique. The pre· 
... ce of .talA indicated. AChE protecUcm b7 the faeWtato17 drup and 
enqme iDhtD1U.n at facUitato..,. do.... Aulo.,.. In !U£! .tudie. w.re 
performed. Small .... of ",.Ufmble and edNphooS.vm, given clo.e 
arteriaUy, and larger d •••• of edrftphoJW.lm, "va lntrav8IlOWI17. 
facilitated neurom'Ucu1ar traAami.8101l without iIlbtblUn, ACbB. 
Ambenold.um, atvan clos8 arteriaUy, and ambenoalurn and ne08tig.mine, 
given 1ntrav •• ...q. 1Dh1blted AChE. Methoapmbenonium produced 
aUght lDhlblti_ "vea m:traveJlGWl17.r cloee uterla1l,.. Alternate 
tbeorle. to the anUeho1lne.tera.e the.17 of the meeh.ani.m ., acUon of 
the.e compoundl are discused. 
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INTRODUCTION 
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t. ANATOMY AND PHYSIOLOGY 
'lbe mechan1am of actton of facUitatory drugs at the neuromuscular 
junction is not yet agreed upon. Disagreement exists as to whether or not 
the drugs in question inhiblt chOlinesterase. The drug •• neoatigmine. 
edrophonium, ambenontum and methOXl'ambenonlum are reveraible inhibitors 
of acetylcholinesterase and the degree of 1nh1biUon in vivo produced by a 
facilitatory dose Is contrcwersi&!. The experimelt" described in this thesis 
were performed with the objective of obtaining more information on this 
point. A short account of the anatolDJ and plv'slo10l1 of the neuromuscular 
junction precedes a review of the present state of the problem. 
A. Junctional Mo;rpholOfl 
a. Gross 
The motor nerve to the anterior tibialis musele consists of ft.bers 
1-20 microns in dlameter. An impulse travels in this type of fiber at a speed 
of 5 ... 120 meters per second with a spike duration, including the absolute and 
relative refractory periods in the order of 0.4 ... 0. Ii milliseconds. The nega .. 
tive after potential ran,.s from 12 to 20 mUltseconds and represents a-5" of 
the spike height. The positive after potential ts 40 ... 80 mUlisecouds in dura-
tion and represents approximately O. 2" of the spike height (Gasser, 1941). 
The nerve divides approximately seven times and innervates in the order of 
120 muscle fibers comprising a motor unit (Sherrtngton. 1925; Clark, 1931). 
The units are not compact but are spread throughout the entire muscle. In 
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most mammalian muscles there is a OI1e to one ratio between nerve branches 
and m.uscle fibers; that 1s, each muscle fiber is innervated by only one nerve 
branch .. The tibialis anterior muscle of the eat has been used for the experi .. 
ments discussed in this thesis and consists of such focally innervated muscle 
fibers. At the terminal the axon loses. its myl1nated sheath (Wagner, 1847). 
Hubbard and Schmidt (1961) have shown that in the motor nerve terminal the 
time course of the action potential!. 1.3 ... 3 millb&econds, the negative after 
potenttalis 15-30mUllseconds, and tile positive after potential is 50 milli-
seconds. These resemble closely the properties of the main axon. 
b. Ultrastructure 
The study of the fine structure of the IB uromuscular junction Is of 
considerable interest for onlJ in the last decade has it been possible, with 
the use of the electron microscope, to find new elements of structure which 
begin to provide a morphological basts for the newer understanding of junc-
tional functiGn. 
The dIagram (fig. 1) illustrates the more important anatomical 
features ef the neuromuscular junction .s stUdied with the aid of the electron 
microscope. Each of the nerve fibers terminates or lies in a synaptic gutter 
of the muscle which is made up of •• eries of foldings called "junctiOl1&I 
folds" (Couteaux, 1944). The receptGrs for the transmitter as well as the 
enzyme necessary for transmitter destruction are believed to be located in 
the junctional folds (Koelle and Friedenwald, 1949; Waaer, 1959). 
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FIGURE 1 
Schematic drawing of a neuronluscular junction as seen with the aid of the 
electron microscope. 
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Synaptic v.sicl.s aN found in the prejunctional or DOnie end.,s. 
These are hollow spherical elements of abeut 100 A 0 in diameter and by 
chemical methods it can be shown that the transmitter acetylcholine and the 
choline-acetylase system for the production of acetylehollq are concentrated 
In the subfraction eoniaininl the synaptic veslcias (De RObertis, Pellegrino 
de lraldl, ROdriguez de Lore. Arnaiz, and 8alpnlcoff, 1961; De RObertis, 
Rodrlgu •• de Lo .. s Aruaia, SalgaDlcoffi PeUegrino de lr81d1, aDd Zieher, 
1983). The vesicles are pOstulated to now towardtbe axome terminal mem-
brane and dischar,e tileell.wcal medtator lilt. the tntermembranale1eft. 
The nerve terminals and ·mu8cl. fibers are .eparated· by continuous 
membranes (Couteaux, leaO). The •• m.embranes show specia.11zatlGn COn-
.ist .... Of patch •• of hi,h e1eetren denslv ea11ed "active petnts" (Couteaux, 
1961). The jUnctional c'-It between the oppHlnr membrane. at these pelats 
18 up to 600 A 0 wide CAnder8son-Ctder,ren, 1959,. The postsynapUc mem-
brane Is depressed at replar i.iltervals into told8 that run at right angle. to 
the fiheraxis and communicate with the extemal space at both 81des of the 
nerve terminals. These junctional folds were named the" subneural 
apparatus" by Couteaux (1947). These tolds aN •• rta.lnq a device fOr 
inereasin, cOllSlderabl¥ the surface of the subaynapUe membrane. 'I'hia 
increa.e bas been caloulated to·be ot abOut 4 ... 6 times (Andersson-CederIND, 
1859). 111 the tro" the lonritudinal spaoing of the folds is rather rep1ar aad 
it has been emphasised that the contacUng portieu of the~.tsynaptio 
membrane stain more heavily (Birks, Huxley, and Katz, 1960). They 
postulate that a special protein layer may be attached to large parts of this 
membrane. It would be tempting to identify this postsynaptic density as the 
locus of chemoreceptive function, but without further proof its role remains 
obscure. 
Koelle and Friedenwald (1949) first showed histochemically the 
existence of a high cholinesterase activity at the level of the motor end-plate. 
The exact localization was, however, obscured by diffusion artifacts. 
Couteaux and Taxi (1952) obta.iued a more accurate localization by slight 
changes in the echnical procedure and found that the structures stained by 
the acetylthiocholine method are identical with the subneural apparatus 
previously identified with supravital methods. They concluded that the 
subsynaptic membrane contributes the major portion of the total cholines-
terase activity. However, recent histochemical studies using electron 
micrographs have shown some cholinesterase to be present presynaptically 
in the membrane and vesicles (Barrnett, 1962). 
Interesting studies have been carried out on the neuromuscular 
junction with the use of radioactive drugs that will bind specifically the 
receptors normally occupied by the transmitter. Waser (1959), using 
radioactive curarine, has calculated tha.t one end-plate contains about 107 
receptors which would occupy only about 2% of the highly folded subsynaptic 
membrane. These receptors might be localized at certain points of this 
membrane and not dispersed throughout it. 
B. Junctional Transmission 
a. Acetylcholine 
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It is now generally accepted that acetylcholine is responsible for the 
transmission of the excitation from the nerve endings to the motor end-plate. 
Brown. Dale and Feldberg (1936) discovered that acetylcholine was involved 
in transmission at the neuromuscular junction by identifying it in the perfu-
sion fluid after stimulating the nerve to the hind limb muscles of the cat. 
Injection of acetylcholine into arteries supplying the gastrocnemius muscle 
caused a quick contraction of the muscle. It has been confirmed that 
stimulation of motor nerves in isolated muscle preparations causes the 
release of acetylcholine (Straughan. 1960). Microelectrode techniques have 
shown the quantity of acetylcholine necessary to produce a response is 1. 5 X 
10- 15 gm. (Krnjevi~ and MUedi. 1958). which because of the narrow gap at 
the junction is a concentration of approximately 1 X 10- 3 M. 
Cholinergic fibers contain an enzyme. choline acetylase. which in th 
presence of adenosinetriphosphate forms acetylcholine by transferring 
acetate from acetyl coenzyme A to choline (Nachmanson and Machado. 1943). 
There is more than enough choline in the olasma to support this synthesis 
no matter how heavy the traffic of nerve impulses. Choline being a 
quaternary compound is unable to penetrate nerve axons by passive diffusion 
so the nerve endings must extract the choline from the extracellular fluid. 
Birks and MacIntosh (1961) have postulated a choline carrier in the terminal 
axonal membrane. The release of the transmitter accelerates its formation 
but the mechanism of this is not understood. Choline acetylase is found all 
along the nerve trunk. Acetylcholine and choline acetylase are stored in the 
synaptic vesicles (De Robertis and Bennett, 1955). Even In the absence of 
nerve impulses there is a spontaneous rel.se of acetylehollne from the nerve 
endings giving rise to minute voltage fluctuations in the region of the motor 
end-plates; miniature end-plate potentials, about 1% of a full end-plate 
potential (Fatt and Katz, 1962). On the arrival 01 a nerve impulse there is a 
simultaneous release of a large number of quanta of acetylcholine. This is 
caused by a depolarization of the terminal causing an influx of caleium which 
alters the properties of the vesicle. Or the axoplasm just inside the membrant 
so that the vesieles spill their contents into the synaptic gap (Birks and 
MacIntosh, 1957). Depletion of calcium reduces the output of acetylchoUae 
and the frequency of minlature discharge. Magnesium lons have;,the opposlte 
effect; an increase in magnesium ion concentration deereases acetylchOline 
output (Del Castillo and Engbaek, 1954; Hubbard, 1961). 
The combination of acetylcholine with its receptOrs makes the end ... 
plate permeable to aU free anions and cations on either side of the membrane 
so that the local potential in this region tends toward an equUibrium level. 
This localized end-plate negativity is known as the end-plate potential. When 
the end-plate petent1al reaches a threshold level (about 1/2 resting value in 
the frog (Naatuk, 1955) or 1/4 resting value in the cat (Boyd and Martin, 
1956) ) the membrane ls short circuited and surrGWldlng areas of the mullele 
membrane,. still in the resting state, discharge into this current sink and a 
muscle action potlilntial is initiated and propagates away from the. end-plate 
region (Eccles, Kate, Kuffler, 1941). The amount of acetylcholine released 
is in exclilss of what is needed to reach threshold (Brown, 1937), and yet it 
disappears quiclt.q allowing the end"'pla.te to repolarize before b end of the 
refractory period of the muscle fiber. 
Cholinesterase is responsible in part for the rapid disappearance of 
acetylchOline but L'le end-plate potential is still short ... lasttng in the presence 
of choUnesterase inhibitors {Eccles, Katz, Kutner, Ui42'. Other mechan-
isms for the rapid removal of acetylcholine, such as rapid diffusion to 
sUDthreshold concentration (O,ston, 1955) or resynthesiS to a chemical 
precurSQr (Abdon. and Bjarke, 1945) have been suggested. The presence of 
cholinesterase may be merely an em.ergency mechanism tor the removal of 
abnormally excessive amounts of acetylcholine. However, the artificial 
conditions of some animal experiments ma.y be what cause it to appear 
wmeeessary. (Blaber, 1962). 
b. Cholinesterase 
The cholineaterases constitute a group of esterases which hydrolyze 
choline esters at a higher rate than other esters. All esterases which show 
this specificity are inhibited 1>1 10-5 of eserine (Richter and Croft, 1942) 
and are much more sensitive to quaternat"'1 ammonium ions than are other 
esterases. This outstanding affinity of cholmesterases for cationic 
1 ,-<: 
substrates and inhibitors is the moat characteristic feature of the.e ensyme., 
and suggests that the active center of choUnesterases, in contrast to other 
esterases, include. a negative group (nanionic stten ) in addition to the ester-
binding group ("esteratic site") (WUson and Bergmann, 1950). 
The exiatence of an enqme responaible for the destruction of the 
humoral transmitter was suspected by Loewi (1921) early in his studies of 
the nvapsatoff" and later demonstrated by Loewt and NavratU (U'2G). Later 
studi •• showed that those portions of skeletal musele that had a high concen-
tration of motor end-plates also contained the most acetylcholinesterase 
(Couteaux aDd Naehmansohn, 1940). The classic investigation by Marnay and 
Naehmanaohn (Ul37) demonstrated that there was enoup acetylcbolinesterase 
in the end-plate region of the frog to hydrolyze, during the few mUliseeonds 
of the refractory period, the amount of acetylcll.line calculated to be 
released from the nerve termtnal. Sim11ar studtesled t. the same cone1u-
slons tor tbe toad (Feng and Ting, 1938). Nerve degeneration e~r1ments 
led to the conclusion. that wbereas there was some acetylcbolinesterase 
activity in tbe terminal nerve branches, most of the enzyme activity was 
localised in the subneural region (Sawyers, Davenport, Alexander, 1950; 
Brooks and Myers, 1952). Refined microchem.leal1nvestlgations bave 
confirmed earlier conclusions that acetylcholinesterase is intimately 
assoc1ated with motor end-plates (Couteaux and Nachman.ohn, 1940). 
.1 ) 
Considerable work. has been devoted to the localization of cholines-
terase in muscles. When oure histochemical techniques are applied to 
normal muscle, cholinesterase is found at the following sites as summed up 
by Beckett and Bourne (1957). 
1. Small classical end-plates arranged in straight rows across riluscle fiber 
or in groups. The cholinesteras. in the end-plates is of two kinds, predoml-
nantly acetylcholinesterale but also butyrocholinesterase (Denz, 1953; 
Holmstedt, 1957). Most of the acetylcholinesterase at the junction is post-
synaptic and belongs to the 150-called subneural apparatus. Very little ia 
presynaptic (Zacks, 1964). 
2. Plates composed of i)8raUel gutters arranged .s a "cake CrUI" or 
palisade, the gutters being oriented in the Sanle direetion as the long ald.s of 
the muscle fiber (Couteaux and Taxi. 1952). 
8. Large cap-shaped areas situated over the ends of ,r1'1usc1. fibers, with 
gutters arranged in paranel or in a somewhat reticular :)attern. These 
endings are .. in fact, situated at the rnu8culo-tendinous junctions (Gerebbolt, 
1959). They are also found where muscle tibers end in the middle of a 
bundle. The pos.1b1lity exists that these I.uay not be n. otor end- plates but 
su-etch receptors"·lf this 18 so, then the :lr.sence in them ot acetylchol1n ... 
esterase 1s of 80me interest. 
4. Cholinesterase is also present in muscle spindles. bOth in the end-plates 
of the intratusal fibers and in the fibers theInselves (Coers and v" ooU" 1959). 
Gerebtzoff (t959. has shown that ,the speed with which a m.usele 
contracts Is dependent more u.pon acetylahoUne sensitivity than upon the 
am.ount of eholin.st.rase preHnt. 
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KaeU.'and c..-... oJ"ker •. haft lnd1cated that the totalneu.roaal 
aee\ylohe11nesteraH eorudet.of a nftmetlonal It portion extemal to a ' 
relatively lm.p4lrrneab1e, .eUular Ddtmbrane and an internal port1_~ It has 
been suggested that the internal or "reserv." portion represents the souree 
for the replacement of the fwtottonalenzyme .1 the _en surface and' could 
pOlsf.bq belden.tlealwlth the endoplallmte Ntteu1um. Ql'ukuda and KGel1 •• 
lt59'. 
n. PHARMACOLOGY 
Numerous compounds capable of facilitating neuromuscular trans .. 
mission. have been synthesized. Many of these have been shown to possess 
anticholinesterase activity and it was natural to ascribe the effects of these 
compounds on skeletal muscle to inhibition of the enzyme at the neuromus-
cular junction with the con.sequent preservation of the transmitter. In recent 
years the lack of correlation between the ability of certain of these compounds 
(See Fig. 2) to facilitate neuromuscular transmission and to inhibit cholines-
teraee in vitro has led to research which shows that some of these compounds 
cause at least a part of their facilitating action via other mechanisms 
(Randall. 1950; Wesco. and Riker, 1951; Riker. 1953; Karczmar. 1957; 
Blaber, 1960; Blaber and Bowman. 1962; Blaber. 1983). 
A. N eostiJD?!!e 
N eostigmtne is a synthetiC anticholinesterase which was developed as 
an outcome of the studies of the chOlinesterase-inhibiting properties of 
physostigmine. Although there is 11ttle difference between the.!!!.!!!!:9 
potenCies of neostigmine and physostigmine to inhibit cholinesterase in 
various speCies (Nachmansohn, Rotherberg and Feld. 1948), the anticurare 
and twitch potentiating action of the former drug is much more rapid in 
onset than that of the latter (Riker and Wellcoe. 1946). The rapidity of action 
of neostigmine compared to that of physostigmine can probably be ascribed 
Simply to a more rapid rate of combination with the receptors (Blaber, 1982). 
FIGURE 2 
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In the rat diaphragm. neosUgmine antagonizes not only the neuro" 
muscular paralysis by curare but also par~sis by depolarizing blockers 
such as decamethonium (Seeher, 1951). Tht. antagonism of depolarizing 
blockade does not bold true blthe cat though, for an increase of the blocka,. 
is observed (Bowman, 1962). Neosttgn'rlne Is knOW]l. to have a direct aetlon 
at the neuromuscular junction in additiOn to its anticholinesterase actiOn 
(Riker and Wes~CIe. 1946), but this has been shown to be too weak to contri-
bute to U. action at the neuromus9ular junction (Slll1th. Cohen, Pelikan, and 
Un$l, 1962; Hobbtger, 19&2; Blaber, 1962). Berman-Retsberi(1957) 
showed u..t neoattgmfnetnhlbtted Choline-acetylase but 8X 10-1 M waa 
neeessary to eause 5010 tnhlb1t1on wb.lch is strlld.ngJ.y difterent from the 
potency to 1nhlbit ace'Vlcholinesterase •. 50" tnlUbttton bein, p1"Qduoed b:; 
2.8 X 10-'1 M, 1. e. at a concentration Of approxtmately 40,000 time. les8. 
'111. finding that drugtl of tIlts type pOtentiate the aetlan of applied acetyl-
choline is me"ly a demonstrattOl'1 that in sufficient concentration they 
posse •• an ant1cbol1nesteras. actiOn. The question of whether this is the 
801., Or even the main mechanism of action of these compounds in the 
lUIual effective do.ses i8 not answered. 
B. EdrophQft1l!tn 
'l"he compOUnd ed1"Ophonlum 18 a particularl, tnterestingsubstance 
beeaus. It reveal. some of the weakness •• in the experimental methods. It 
18 a quaternary compound whleh 1Bhf.blts the enfl7me reversibly by eomb1nJ.l1ft 
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with it onl\Y at the anionic site, and thus blocks attachment of the substrate 
(Holmatedt, 1959). 
The rapid on.set and short duration of action of edrophoniurn with 
respect to neostig::.n1ne has been noted by a number of blvesUgators (Cowan, 
1988; Macf arl.a.ne, Pelikan and Unna, 1950, Riker, 1953; \VUSOll, 1955). The 
ability of this COlA.'lpound to reverse the nellromuscu!ar blocking aotion of 
tubocurarine is well kno\\n also, but t. .... e earliest experiments indicated that 
it was only a feeble allticholinest~n'3.se, about one-hundredth aa potent as 
neostigmine (Randall .. 1950; Hobbiger, 1952). It was of interest to compare 
the time course of action and potency ot this compound in vitro and in vivo, 
........... ---- ---~ 
since it had been presumed that the anticurare and acetylcholine potentiating 
properties of edrophoniuIU and neostigmille are primarily the result at their 
anticholinesterase activity. Smith, Cohen, Pelikan, and Unna (1952) 
obtained results which indicated thatedrophon1urll was as luuch as Qne-quar-
tel' as active as neostigmine. These same workers found that there was no 
positive correlation between the relative potenCies of the compOund as an 
anticholinesterase and its abU1ty as potentiator of acetylcholine on the 
frog rectus muscle. The 'inhibition of cholinesterase byedrophonium was 
reversed by the addition of substrate too rapidly for the time course to be . 
measured with the manomeu'ie teehn1que. The evidence obtained neither 
directly confirmed nor negated the thesis that the potentiation of acetyl-
choUne and antagonism of tubocurarine produced by this compound is the 
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result of its inhibition of cholinesterase (Smith, Mea.d, and Unna, 1957). 
¥/nson showed (1955) that for the acetylcholinesterase of eleetrlc eel 
at 20° C, Ki for edrophonium W1UJ 3 X 10 ... 7 as opposed to 10.7 for 
neosttgmin.e. Th~ rate of fo!'mation (and of dissociation) for the complex 
'with edrophonium, was much greater than that for neostigmine. Contrary 
to observations 'With neo:!tlgmine, potentiation of l."esponse toacetyleboline 
is ma.ximal a.fter an e:!.::posure to edrophonium for only two minutEts or les8 
and decreases subsequently over a period oi 10 to 20 minutes untn it 
rea.ches an equilibrium value. The formation of the enzym.e·inhibitor 
complex in the absence of substrate is completed in IS seconds. The 
reverse reaetion proceeds rapidly also (one-half dissociation \vas not more 
than 30 seconds). The one-half Ume dissociation tor neostigmine 1s about 
12 minutes (WUson, 1955). If the experiments were performed in equili-
brium conditions this should not affect the results, but if the ass()(:iation and 
dissoelation of neostigmine does not have time to reach equtlibrium, it may 
appear very much more powerful than edrophonium; in these circumstances 
it is, in fact, behaving as a non-competitive "irreversible It inhibitor 
(Wilson, 1955). 
c. Oxamides 
Ambenonium ehlorlde(Mytelase: WIN 8077) and methoxyambenon1um 
chloride (WIN 8078) are members of a series of btsquaternary oxamides 
synthesIzed in the Sterling-Winthrop laboratories and first reported by 
Arnold, Soria and Kirchner (1954). Both are fl7MtrglaUc with neoet1arnme in 
mice and both lacUitate traa8miaaiOl1 aDd oppose blockade ill the a~d3 
nel'"YOWl .yatem (Karcamar and Howard, 1965). Both eompounda.have bee. 
shown to be rever.iDle 1nbiDltora of aeevlcho1taesterue (Karcamar and 
Howard, 1965: Koelle, 1957; Bla.er, 1960). hl tb1a regard it wu fOWld fAat 
ambenontum 111 more than 100 time. as active u metboqambenonium. 
AmbenoDium diaaoc1atiOll occurs extremeJ7 81ow17 exceptiAgin the p .... ence 
of relatively hiab coaeentraU .. 01 certalncaUou (KoeUe, 195'). Amlte .. -
atwn potent1a.te. the respe ... to th. indirect af.ngle shock stimulation of cat 
mud. ancl aataaonla_ curare blockade. AlthOllgh a powerful &aU-curare 
agem. me.UJambeaOD1um does not potentiate the maximal twitch wl1IIlon 
(Landa and Karczmar, 1951: Blaber, 1910). Ambenonlum wlU e11cit twitch 
r .. pou •• on cl08e al1er1al1ajeeUoa aw.l aUg:tlle¥lt the excitatory aDd 
paraqz1n. acUoa of acetylehoUne, succiD.ylcbOUUa and decametAon11am. on the 
eatf • UbialU Inuada. Karczmar (1967) showed that methoqambenoa1um 
produced re.eraal of the aeU_ of 8ucc1n71chollne... decamethonium on tne 
eat'. tibl.aU8 muae1e. Alao, since methoqam,beDoldum aatagon1s •• pal'aqala 
by curare and depctlarbinl a,_tat as well, Kuczmar streBs.d 10 his diacu-
aloa that the curreut theone. on the mode of acUon of the depo1arizer. 
offered an 1Daclequate explaaaUon tor the properU.s of metboqambenoDtum. 
Blabe .. (980).flBdlag tbat both ambenODium uo methoqambenoldUID 
.... lOniz.d the paralJ'.'a of curare and depctlarbera, arrived at the conclu-
al_ that larger dOM. thaD those required to aata,ontae curare are needed 
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to remre transmis.lon from. paral7.t. by deoaxnethom.um. Blabqt al .. 
fOlmCl at th •• e htah ... d ... , oxamide. produced a neuromuscular block 
reaem.bliDI iD m&rI7 _,.8 that cauaed by eura.... AccordiDl11, he ...... ted 
that the anta,OId.sm of depolaris.rs was due to the cUr&NmlmeUc properti •• 
of the o.mkle •• 
The comp1exlv of •• detat1ed meehaa1.m of actloD. of ... mide. ,. 
apparent; there 1. DO correlatton between the .. elative ,..acy of the ...... nt. 
curare ta that it ... antapnlNcl by tetanic .UmulatlOll aad upe1aristng ..,ent., 
It ... unlike that produced by curare 1D. that it 1. not antapaised by neoau,-
m!ae or eclrophomum (Blaber, ·1 ... ). 
D. DFP 
-
AaUchoU.nestera .. s. neb .. uoattp1.iD.e and edrophODium.. InIdbit 
the ftl.7m.e "reveratbl1" by .om.b1DID, with It an.d bloekJat attachirlent of the 
substrate. Caretw. ldaeUc studt •• have """e .own that oaq De,u,tble 
amouate of aD. iDhiblto .. of this .,.,. are ... l .... eeI ...... eraib17 from the e..,me, 
1D.cleecl, ueoatt,mJu ... tv'dro17s" eztrem.elJ Ill". b.Y chollne8tera .. 
(W1la0ll, 18SI). 
effect 81nU1ar to th ••• of ........... neh a .... rtne 0 .. aeoau,rrua. are 
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(Koster, 1946). With the isopropyl group on the enzyme virtually no hydro-
lysis occurs and the return of cholinesterase activity depends on the forma-
tion of a new enzyme (Wilson and Bergmann, 1950). Their action is often 
described as "irreversible, II but this is slightly misleading. Augustinsson 
and Nachmansohn (1949) observed that the inhibiti:.on of cholinesterases by 
DFP was not competitive; the reaction can be regarded as being roughly 
a non-competitive one. This only implies. however, that the stability of 
the enzyme-substrate comples is so great that it is unlikely to be broken 
up U1..!!.y£. The affinities of the organophosphorus compounds for the active 
center are not very different from those of the "reverSible" inhibitors, 
such as eserine or neostigmine (Davison, 1955; Burgen and Hobbiger, 1951; 
Hobbiger, 1954; TammeUn, 1958). It is apparent that the terms "reverSible" 
and Hirreversible" as applied to these two types of anticholinesterases renec 
only quantitative differences, and that both classes of drugs react with the 
enzyme in essentially the same manner as does the natural substrate. 
DFP (diisopropyl phosphorofiuoridate) was synthesized by McCombie 
and Saunders in 1946' and is considered an "irreversible" anticholinesterase. 
After DFP treatment recovery of blood and tissue cholinesterase depends 
on alkyl radicals and new enzyme synthesis (Blaber and Creasey, 1960a, b; 
Koenig and Koelle, 1961). Recovery of erythrocyte cholinesterase is 
4.40/0 per day for the first 15 days and thereafter it is decreased tp 
approximately 0.8% per day (Oberst and Christensen, 1956). Studies 
indicate that ;;0 to 80% of the total cholinesterase of nervous tissue or 
effector organs must be inactivated before pharmacological action8 are 
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noted (Koelle and Gilman. 1946; Riker and Vi, escoe, 1949; Kamijo and Koelle, 
1952). Cause of death in DFP poisoning is respiratory fallure and in this 
regard 1t haa been shown that lmpe.inllent of neuromuscular transmission 
Gee •• firat, with fallure of the central mechan1sm immediately following 
(\\i right. 1954). 
Koelle (1950, 1951, 1955. 1957) haa used DFP for the ];>urpoa. of 
determining cholinesterase inhibition by so-called "reversible inhtbitors. " 
Usin, cytological localization of the enzyme as a techn1que he baa shown that 
the "reversible" compounds will protect the enzyme from attachment with 
an "irreversible" compound such .. s DFP. If the reveralble compound 
inhibits the enzyme. it protects against OFF and upon d11uUon the enzyme 
can be local1zed. If the test compound does not inhibit cholinesterase it wW 
not protect against DIfP and an irreversible inhibition 18 obtained and the 
enzyme cannot be localized.. In short, if a compound does not protect the 
enzyme against DFF it 18 not coutdered a Il reverslblell an'tic1lo11n.estera ••• 
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In. mSTOCHEMISTRY 
lbere are two general approaches to the cytc.)logicallocal1zatien of 
sites of drug action: 1) to demonstrate at the cellular level the distribution 
of the active drug following its administration or 2) to demonstrate changes 
in a specific group or compound with which the drug 1. known to act. Because 
the compounds we are interested in are reported to have an anticholinesterase 
action we shall choose the second approach. 
As an example of the qtological approach to pharmacoloQ, the 
anticholinesterase a,ents represent a particularly favorable class of drugs. 
The primary mechanism of action. of these agents is the inhibition or 
inactivation of cholinesterase. The thiocholine method of Koelle, when 
properly contrOlled, 1. bOth highly specific and extremely sensitive for the 
localization of cholinesterases. The exact site of choline ate rase, in relation 
to the structural elements of various tissues, had been a matter of uncer-
tainty before Koelle's technique beeame available. AcetyltlUoeholine, used 
as the substrate in this technique, was first liyntheslzed by Renshaw (1938) 
who noted that its pharmacol.,ical actions were similar to those of acetyl-
choline but of briefer duration. It Is known that it is hydrolyzed at a more 
rapid rate than acetylcholine by cholinesterases, because of the weaker 
linkage of the -c-s ... than the -C-O .. bond. The present experiments will not 
attempt to differentiate between the dUferent types of cholinesterases because 
in the area that is under study, the neurom)"al junction, the amount of 
~3 
acetylcholinesterase represents approximately 950/0 of the cholinesterase 
present in the area (Giaeoblnt and Holmstedt, 1980). 
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IV. PURPOSE 
Blaber (1963), comparing the saIne drugs as used in the present work, 
found that their abUity to potentiate the muscle contraction produced by at 
close-arterial injection of' acetylcholine was clesely correlated with their 
in vitro anticholinesterase potency. However, there was no correlation 
--
between J!! vitro anticholinesterase potency and their abiUty to potentiate 
the muscle twitch elicited by the stimulation of the nerve, or with their 
anti-curare activity. It was concluded that some action, in addition to 
inhibItion of chollnesterase, contributed to their facilitation at the neuro-
muscular junction, and it was suggested that this action may be at the 
prejunctional site. 
The purpose of the present work is to tl")' and provide more direct 
evidence on the ability of thea. compounds to inhibit cholinesterase at the 
dose levels Blaber used by observing their effeet on muscle twitch, ,removin, 
the muscle and staining for cholinesterase using the 1951 acetylthfocholine 
method of Keelle. 
MA TEBlALS AND METHODS 
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I. IN VIVO PREPARATION 
Forty-two adult cats were used in th~se experiments ranging in weight 
from 2.0 to 3.5 kg. The animals were anesthetized with choloralose 
(80 mg/kg) intra pe ritoneally , fastened to the operating table in a supine 
position and the trachea cannUlated. A polyethylene cannula was placed in the 
lett femoral artery and connected to a Stratham pressure transducer for the 
purpose of recording blood pressure. To prevent clotting this cannula was 
filled with heparin solution (200 units per mI.). Blood pressure was recorde 
to provide an index of the animal's condition during the experiment. 
A. Preparation For The Administration Of Drugs 
The left femoral vein was cannulated for intravenous drug administra-
tion. The polyethylene cannula was connected to a three-way stopcock and 
clamped to a support of the operating table. Since both left femoral vessels 
were cannulated, the left anterior tibialis muscle received none of the drugs 
administered and acted as a control muscle. In experiments requiring clOse 
arterial injection of the test drugs, Blaber's (1960) modification of Brown's 
(1938) method was used. The artery to the anterior tibialis muscle was 
cannulated and the polyethylene cannula rUled with heparin solution (l00 units 
per mi.), plugged untU ready for use and fastened to a support of the oper-
ating table. The right femoral artery and vein were exposed and a string 
passed around the artery. For close arterial injections the femoral artery 
was occluded as the drug was injected thereby assuring the drug did pass 
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into the tibialis muscle. In all experiments tbe string was used to 11gate both 
tbe femoral artery and vein shortly after all drugs had been administered. 
B. Recording Of Mechanical ResP'!l;se 
The right anterior tibialis muscle was exposed from mid-calf level to 
its \ tendon insertion. The tendon was l1gatured and cut, from the bone of its t 
insertion. The sciatic nerve on the right side was exposed and cut high in the 
thigh. This was for the purpose of elimiDattng reflex responses during 
muscle twitch recording. The nerve to the tibialis was then exposed on the 
outer border of that muscle. Drills were inserted into the lower end of the 
femur and the lower end of the fibula and tibia and the limb was rigidly 
clamped in a horizontal position to the operating table. The ligature around 
the tendon of the muscle was connected to a Grass Model 1fT-l0 force dis ... 
placement transducer for the purpose of recording mechanical twitch. A 
shielded platinum electrode was placed on the tibial nerve distal to the 
severed sciatic nerve and connected to a Bioelectric Instrument isolator 
which received pulses from a stimulator consisting ofa Textr<mtx Type 162 
wavetorm generator and a Type 161 pulse generator. The cathode of the 
electrode was placed nearest the muscle and a rectangular pulse Of 50 micro 
seconds duration and twice the strength needed for maximal stimulation was 
used at a frequency of once every 10 seconds. A temperature probe was 
placed in the belly of the muscle and the muscle covered with a surgical 
sponge mOistened with mineral oU. The muscle was maintained at 37°C 
with heat lamps. 
C. Experimelltal Procedure 
The blood pressure, muscle twitch, and temperature were all moni-
tored on an Offner Type R Dynograph. There was a 30 minute control period 
of muscle twitches prior to the injection of drugs. After the control period a 
reversible fac1l1tatory agent was given. The drugs were given either 250 
micrograms intravenously or 5 micrograms (total dose) close-arterially. 
All drugs injected, including DFP, were dissolved in O. 90/0 saline solution. 
Saline was also used to wash intravenous injections into the felnoral venous 
cannula. Close-arterial injections to the anterior tibialis were administered 
retrogradely into the central end of the ligated tibial artery below the anterio 
tibialis muscle. At the moment of injection the femoral artery was occluded. 
The ligature around the femoral artery was released following the injection 
of the drug and the cannula was washed through with heparin solution (100 
O. 9% 
units per ml. in NaCl). OFP was always given intravenously (15 mg/kg). 
The OFP was dissolved in 0.90/0 saline in a concentration of 10 mg/ml and the 
solution prepared within one hour of its injection. In the case of those drugs 
which augmented the muscle twitch, the 15 'rag /kg dose of OFP was injected 
at the point of greatest augmentation and if there was no increase in muscle 
twitch the PFP was given intravenously 30 seconds after the reversible 
facUitatory agent had been injected. At the peak of augmentation of the 
muscle twitch caused by DFP the right femoral artery and vein were tied off 
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and the stini ulue to the a.nterior tibialis stopped. (This procedure was to 
make certain the drugs were not com.pletely washed out of the muscle into 
the Circulation). The muscle was then m.aintained at 3S-3aoe for one hour. 
After the one hour incubation period of the {Huscle in situ it was removed, 
immediately placed in a glass container, covered and placed in the freezer 
compartment of the refrigertor. The animals which survived the organo-
phosphate toxicity were sacrificed by the irlJection of 30 cc of air into the 
femoral vein. The left anterior tibialis muscle was removed and frozen 
in the same manner as the right muscle. 
D. Histochemistry 
a. Preparation of Sections 
After the muscle was completely frozen a trapezoidal cross- section 
of the distal one- half of the muscle was removed and placed on a micro-
tome planchet. A few drops of water were added to the planchet and the 
planchet with the muscle on it was then placed into the freezing microtome 
so that the muscle would become fixed to the planchet. The muscle was 
then sectioned in the microtome in 10-15 micron sections and placed on 
glass slides which had previously been frozen in the microtom.e. The sUdes 
with the muscle sections on them were placed at room temperature until 
thawing caused adherance of the m.uscle sections to the glass. This usually 
was 15 to 30 seconds. They were then ready to be placed in the incubation 
solution. 
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b. Staining Procedure 
The histochemical approach for the determination of antichol1nester-
ase potency in the present study is based on Koster's (1946) observation that 
a reversible inhibitor can prevent the lethal action of DFP by transient 
competitive combination with the enzyme (Koelle, 1946). The technique 
outlined below is Koelle's 1951 method. As developed originally (Koelle and 
Friedenwald, 1949), it consists in incubating fresh frozen sections in a 
medium containing acetylthiocholine and copper glyclnatej as the substrate is 
hydrolyzed by acetylchOlinesterase the thiocholine liberated is preCipitated 
as a mercaptide salt" e. g., copper thiocholine sulfate. The initial concen-
tration of the substrate (acetylthioehoUne) of 5 X 10-8 M, is the optimal 
concentration of acetylcholine for specific cholinesterase (Augustinsson, 
1949). Immersion in ammonium sulfide converts the white precipitate of 
copper thiocholine to a dark brown preCipitate of copper sulfide 'Which can 
then be viewed with an ordinary microscope. 
~cetylthlochol1ne ion 
(NH4)2S 
CuS ~(----------------
Thioeholine ion 
(plus copper glycinate) 
(CuSCH2CH2N( CHS)S)SO 4::' 
Copper thiochoUne sulfate 
REAGENTS 
1. Copper-Glycine: 
2. Maleate Butfer: 
3. Sodium Sulfate: 
4. MagnesiUm Chloride: 
5. AcetylthiochoUne: 
8. CopperthlochOline: 
7. Incubation Solution: 
8. Ammonium Sulfide: 
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3.75 gm.glycine, 2.50 gm. copper sulfate q. s. 
100 mIs. 
9. 80,m. sodium maleate, 52.2 mls. sodium 
hydroxide, q. s. 100. 0 mls. 
40 per cent sodium sulfate (W IV), adjusted to 
pH !. 00, stored at SSoC. 
9. 52 am. magnesium chloride, q. s. 100. 0 mIs. 
'8 mgm. acetylthiOChoUne iodide, 2.' mls. 
water, O. 8 ml. 0.1 M copper sulfate; centrifuged 
supernatant decanted off and saved. 
Obtained by filtering incubation solutions immedi-
ately after removal of sUdes, storing at SSoC.fo 
two to four days to permit spontaneous hydrob"sis 
of substrate, eollecUng preCipitate by centrifu-
ption and washing with water. 
o. (I mi. solution 1, o. (I ml. water, 1.5 mls. 
solution 2, 10. 5 m1s. solution 3, O. 6 ml. solu-
tion 4, 1.2 mIs. solution 5, trace of solution 6. 
25 mls. absolute alcohol, 4. 5 mIs. ammonium 
hydroxide, 3 mls. water; saturated with hydro-
,en sulfide; tested for saturation with 1 drop 
0.1 M copper sulfate; fUtered just prior to use. 
All slides were marlted with a diamond pencU for identification and 
placed in the incubation solution for a period of 20 minutes. Tbey were then 
transferred to a rinse solution of 200/0 sodium sulfate for 6 minutes and then 
immersed for 2 minutes in 10% sodium. sulfate. This was followed by dip-
ping them in distilled water for SO seconds and transferring them to the 
ammonium sulfide developing solution for a period of 2 minutes. They were 
then stained and dehydrated by one minute rinses in alcohol and eosin, 
alcohol, xylol, and another xylol solution. All the above solutions were 
saturated with the reaction product by adding a trace of copperthiocholine. 
The saturation of the substrate solution with the reaction product bas the 
advantage tl:a t diffusion of reaction prod-Ilet is greatly diminished or sup-
pressed. In order to minimize spontaneous hydro~ sis of the substrate 
(ace'tylthiocholine) it was added immediately before the incubation solution 
was to be employed. The solution was stirred and fUtered through Whatman 
#J 1 filter paper into Coplin jars previously warmed in the incubator. 
After the final xylol rinse the slides were mounted with Permount 
(Fisher) and a cover slip. Slides were then viewed under a microscope at 
SOX and photographed. All photOmicrographs were taken with the same 
intensity of lighting, time of exposure, and not retouched. 
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U. IN VITRO PREPARATION 
Adult cats were anesthetized Intraperltonea1ly with choloralose 
(80 mg/kg). The right anterior tibialis muscle was removed from the animal 
and placed in a glass container. covered and frozen in the freezer compart-
ment of a refrigerator. After the muscle was completely frozen. a trape-
zoidal cross-section of the distal one-halt of the muscle was removed and 
placed on a microtome planchet. A few drops of water were added to the 
planchet and both the planchet' and muscle were then placed in a freezing 
microtome in order that the muscle would be fixed to the planchet. When 
this had taken place ten ... fifteen micron fresh frozen sections ·of the muscle 
were cut on the microtome and placed on slides. As soon as the sections 
had thawed and the excess moisture evaporated the slides were placed tor 5 
minutes in a Coplin jar containing a solution of the follOwing composition: 
24,. sodium sulfate. 0.033 M magnesium chloride. and one of the reversible 
facUitatory drugs in a molar concentration calculated to be that which was 
in the animal's extracellular fluid following its injection in the in vivo 
preparation (assuming that a eat's extracellular fluid represents 15% of its 
body weight). The reversible inhibitor was omitted from two sets of controls 
All slides excepting one set of controls were then transferred to a solution 
which contained the same components as above plus 10-4 M DFP. The slides 
were incubated in this solution for 30 minutes at 380 C. and then placed in a 
rinse solution (24% sodium sulfate. 0.033 M magnesium chloride) in which 
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they were kept for 30 minutes at room temperature. This latter step was 
repeated. All slides (including the first set of controls) were then ready to 
be placed in the Koelle incubation solution and to follow the same procedure 
as the in vivo muscle slides. 
RESULTS 
;.;;sb 
Before the rnain experbnents could be carried out it ',\I as necessary to 
find the .m vivo concentration of DFP which vi/ould consistently inhibit cholin'" 
esterue to such an extent that no staining of the enzyme could be demonstra-
ted. The in vitro concentraUons,vhich have been used in this method [or 
--
inhibition of specl.flc eaterues range from 1 X 10- 1 M (Koelle. 1951) to 
1 X 10 .. 4 M (Koelle, 1957). We would expect the Ja.!!I2...concentratlon to be 
similar. Using increasing doses of D,F'P it \'.'a8 found that 15 mg/kg 1. v. was 
the lowest dose of the organophosphate which would consistently InW.blt 
stalaln, of cholinesterue (fig. 3). Assuming the extracenular auld to be 
150/0 of the body weight the.!!l. vivo molar concentration of DFP in the extra-
cellular nuid wu 1 X 10 .. 4 M. 
The hlstocher.nical approach to deternlination of the antichollnesteraae 
actions of aInbenomuro, neostigmine, edrophoniUIll and rnethoxyarnbenonium 
18 based on the observation that the reversible inhibitor, pbysostigmine, can 
protect cats from the lethal action of the irreverSible anUchol1neaterue 
agent OFP (Koster, 1946) by transient competitive combination with the 
enzyme (Koelle, 1946: Koelle and Koelle, 1959). Therefore, the reversible 
lDh1bltor was given immediately before a dose of DFP auff1clent, U given 
alone. to cause practically complete inactivation of the acetylcholinesterase 
al a given tissue. Tbe excesa DFP and the reversible inhibitor was then sub-
aequenily removed; any residual acetylcholinesterase activity sbould repre-
sent that which was inhibited by the reversible inhibitor at the Urne the DFP 
was glven. 
In Vivo 
F IGURE 3 
CONTROLS 
NORMAL 
DFP TREATED 
3 7 
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In the following results inhibition of muscle cholinesterase by OFP 
is indicated by absence of staining in the photomicrographs and shows that 
the test drug did not protect the enzy-tne from DFP and was therefore not 
inhibiting cholinesterase at the time the OFP was injected. Staining of the 
end-plates in the photo,raphs indicates that the test drug was protecting or 
inhibiting the ellzy-me at the time the OFP was injected and reversed during 
the staining procedure. 
I. IN VIVO _ .
A. Ne9lUgmine 
The results with thls compound are shown in fig. 4. The pbotonl1-
crographs show that at the close-arterial dose there 18 no staining of the 
enzyme. We can take this to mean that ne08tig;miDe did not inhibit the 
enzym.e prior to DFP treatmeat so that the organophosphate gained access to 
it. The photomicrograph of the intravenous dose allows atainlng 80 that 
neostigmine was proteettng the enzyme from DFF in this situation. The 
muscle twitch wu faeW:tated with both coacentrations of neostigmine to the 
same extent and tba,t wu augmented further upon the addiUon of DFP. The 
animals receiving the low dose of neoeUgmJ,ne died during the incubation 
period with aU the signs of organophosphate poisoning. The animals 
receiving the htgher dose of neoatlgnline did not die after DFP althougb matty' 
of the sips of pol.ODing were apparent. 
B. Edroggsmium 
The results of cho11nesteraee stalnlDg wUh this compound are shown 
in fig. 5. Neither close-arterial or intravenous dose. protect apinst DFP. 
The muscle tw1tell was tacWtated to the aame extent with both concentratl0D8 
and was lurtber increased after adm1nistratlon of OFP. AU animals died 
during the incubationpenod In. viTO showlng insufficient protection of the 
enzyme against DFP by edrophonlum. The increase in twitch with both 
eoncentrattOD8 of edrophonium before the DFP was adm1n1stered was in 
F IGURE 4 
NEOSTIGMINE IN VIVQ~ 
250 ug. i . v. 
5 ug. c. a . 
40 
-
FIGURE 5 
EDROPHONIUM IN VIVO 
250 ug. i. v. 
5 ug. c. a. 
absence of any sign of fasciculations or other anticholinesterase intoxication 
signs. This has been observed by other workers (Blaber and Bowman. 1959). 
c. Metho~ambenoni~ 
The staIning produced by this compound differed from the rest since 
it was in such a small amount when it was observed. Since the Koelle meth 
is mainly qualitative the results were planned to be either plus or minus 
with little hope of any quantitation or Hpartial staining. If However. as shown 
in fig. 6 there is definitely only partial staining. This appears as uniform 
"hairlike" staining of acetylcholinesterase around the endplate. This type 
of staining indicates that methoxyambenonium does not protect the enzyme as 
well as neostigmine or ambenonium. The smaller dose of methoxyambenon-
tum shows no protection at all against the action of DFP. This is in agree-
ment with other workers who have found this compound to be a weak anti .. 
cholinesterase (Karczmar and Howard. 1955; Koelle. 1957; Blaber. 1960). 
It was also noted with this compound that there was an increase in muscle 
twitch in four out of six experiments using the larger dose of the drug. which 
is contrary to results of other worker.s (Karczmar, 1957. Blaber, 1960). 
In one case with methoxyambenonium the animal died although partial 
staining of acetylcholinef'tet"ale occurred. The maximal twitch was not 
potentiated in this case. In all cases the animals were in poor condition 
during the in vivo incubation period of the muscle with all but one of the 
animals dying of those given the low dose of methoxyambenonium. 
FIGURE 6 4 3.. 
METHOXYAMBENONIUM IN VIVO 
250 ug. 1. v. 
5 ug. c. a. 
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D. Ambenonium 
Figure 7 shows that tbis compound stains well with the intravenous 
or close-arterial dose of the drug. Staining of cholinesterase when this 
compound is used to protect the enzyme against OFP is expected at even 
lower doses than used here (Koelle, 1951). There ia evidence from tneae 
photographs that the amount of staining is greater here than it was in tne 
control aections. The increase in twitch with both dos.s was greater 
compared to that tlbtained with all other facilitators. Thls facilitation 
was such that the injection of OFP did not increase it further. There 
were fasciculations and other signs similar to those seen in the course 
of organophosphate poisoning before the DFP was given; however, none 
of the animals died after DFF, so the compound seemed capable of 
protecting against the lethal affects of DFP. 
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FIGURE 7 
A MBENONIUM IN VIVO_ 
250 ug. i. v. 
5 ug. c. a. 
II. ~ VITRO 
A. Neostigmine 
The results..!!!!!!!:£>with this compound are shown in fig. 8. These 
pictures mimic those of the!!!. '!.!!2 results with this compound. There 
appears to be some diffusion that was not apparent!!!. !1.:!:2. However. 
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the low concentration (3. 32 X 10 M) of neostigmine shows no staining 
as before and, likewise, the higher concentration (1. 65 X 10'" 6M) 
shows staining. 
B. Edrophonium 
Figure 9 show the results with edrophonium. These are the same 
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as those found !!!. ~ showing no staining at either the low (5. 52 X 10 M) 
or high (2.76 X 1O-6M) concentration. Unless concentrations of 1 X lO-3M 
edrophonium are used with this technique the end-plates are not expected 
to stain (Christoff, Anderson, S1otwiner, and Song. 1966). 
c. Methoxyambenonium 
The results with methoxyambenonium are shown 1n fig. 10. These 
were not the same as those seen!!!.!!!9. With the higher concentration 
(9.25 X 10-7M) we see the "hairlike" pa.al staining which we assume 
is partial protection of the enzyme by the compound. Here, however. 
this type of staining occurred also at the lower concentration (1.85 X lO-8M) 
The amount of staining seen in the sections does not appear to differ. 
FIGURE 8 
NEOSTIGMINE IN VITRO 
1.65 X l O- 8M 
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FIGURE 9 
EDROPHONIUM IN VITRO 
F IGURE 10 
4 9 
METHOXYAMBE NONIUM IN VITRO 
10- 8 1. 85 X .l. 1\4 
D. Ambenoniu$ 
With this co.mpound there was staining: at both the low (1. 83 X lO-8M) 
and high (9. 15 X 10-7 M) concentrations. Figure 11 indicates a more intense 
stain than that of the control sections so that these results are in agree-
ment with those obtained in vivo. The in vivo and in vitro results with 
..................... --~ ........................... 
this compound show a much greater amount of stain occurring with it 
than with the methoxy derivative. This would agree with others who 
have found it to be 100 times .s potent an inhibitor of cholinesterase 
as methoxyambenonium (Koene, 1957; Blaber, 1960). 
FIGURE 11 51 
AMBENONIUM IN VITRO 
--- -
1.,83 X lO-8M 
, 
DISCUSSION 
The results presented in this thesis (fig. 12) have demonstrated a 
lack of correlation between the abUities of certain facllitatory drugs to 
potentiate the maximal indirect twitch and to inhibit the acetylcholinesterase 
present in skeletal muscle. These results therefore support the conclusions 
of others (Randall, 1950; Wescoe and Riker, 1951; Riker, 1953; Karczmar, 
1957; Blaber, 1980; Blaber and Bowman, 1982; Blaber, 1983 a, b) that some 
action or actions, in addition to cholinesterase inhibition, play an important 
part in the ability of these drugs to potentiate the responses of the musele 
to nerve stimulation. 
In the present experiments ambenontum proved to be the most potent 
anticholinesterase of the drugs used. FollOWing the injection of this com-
pound the amount of choJJ.nesterase staining, the increase in the size of 
muscle twitch, and the fasclculationa Observed in the ammals all pOinted to 
cholinesterase inhibition. It also proved capable of protecting the animal 
against the lethal dose of DFP even though it produced signs similar to 
organophosphate poisoning. This compound certainl7 may cause factlltatlon 
at the neuromuscular junction through an anticholinesterase action. 
Edrophonium was not inhibiting cholinesterase at the dose levels used 
in the experiments, or it was rapidly disassociated in the presence of DFP 
in a similar way to that described by Wilson (1965) in the presence of 
acetylcholine. It has been shown recently that concentrations of the order 
of 1 X 10· 3 M of edrophonium are necessary with this technique before 
FIGURE 12 
SUMMARY OF RESULTS 
ACHE INHIBITION 
INVIVO INVITRO 
DRUG 
250 IJg I.v. 5 IJg c.o. Low Conc. High Conc. 
NEOSTIGMINE + - - + 
EDROPHONIUM 
- - - -
AMBENONIUM + + + + 
METHOXY- +- +- +--AMBENONIUM 
staining of cholinesterue wUl appear (Christoff, Anderson, Slotwlner and 
Song. 1966). In microelectrode studies anticholinesterase effects are seen 
with edrophomwn, bUt at concentrations higher than the lower dose used in 
the present experirnents which caused an increase in fllusc1e twitch (ChriSt. 
personal comrr.un1cation). The lack of faaclculations or other antich.olines'" 
terase signa following the achninistratioD of edrophon1urn and before the DFP 
was liven coupled with the absence of hiBtochemical staining would substan-
t1ate a theory that the increase in " .. :.usele twitch .. '\I ith edrophonium may be 
caused via a mechanism other than cholinesterase inhibition. 
In the present studt.s the low concentration of n .. etboxyambenomum 
produced some ?rotectionja vitrs! but ienerally not 19. ~ The high con· 
centration also appeared to produce only partial protection. This may indJ. ... 
cat. that the as.ociat1on ot the drug vvitb the cholinesterase molecule is slow, 
and at the low concentrationJ,Q vivo there was insufficient t.tm.. lor any 
appreciable inhibition. The facU1taUon Ot Alluscle twitch was immediate. 
and the anticurare effect of the cOlnpound has also been reported to oe rapid 
(Blaber, 19(0). The total absence of atG" observable anticholinesterase 
signs in the animal preceding the injection of DFP coupled with the anUcurare 
potenc)" of this compound would certainly impl.;y a n:..echanisrrJ. ot action for thi 
compound other than choUnesterase inhibition. The alight staining of the 
enzym.e in the present experiments proved to be inadequate to cause any 
signs of cholinesterase inhibition that we would expect and was unable to 
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protect the animal from the DFF. This may mean that the eholinesterase 
molecule is a usecondary" or • tertiary receptorf! for this COIn pound. Tm t 
is, only at higher dose levels than used in the present experinJientsl.vould the 
anticholinesterase action of this compound possibly contribute ed.f,rnificantly 
to its effects. Compounds \vhich have an effect at the l'leUrOXlluscular junc-
tion would be expected to fit rnany r'eceptors in that area. but each rece~tor's 
a.ttraction to a particular compound is different. The fact that r:netnoxyam-
benoniwn is very aIm\' to dissociate from cholinesterase (Koelle. 1957) may 
a.ccount for the compound possessing little anticholinesterase)otency and 
yet still remain on therLolecule throughout the DFP treatrnent and staining 
procedure. 
In low doses neostifilnine gave gross and htstocherrJ.ical signs simUar 
to those obtained with edrophonium, 1. e., an increase in muscle twitch 
without gross anticholinesterase signs in the animal or any histochemical 
staining of cholinesterase, and the animal dying after Dfi-tP treatnlent. i'lli 
an mcrease in dose. neostigmine gave results liltethose obtained wlt.'l 
arnbenoniunl. There were fasciculations in the anirrl.al, a large in.crease in 
muscle twitch, protection against the lethal effects of DFP, and hlstocherrl.i-
cal staining of choUnesterase. It ',I) auld therefore seem that neostigrl1ine in 
lower doses exerts its action on a receptor other than tne cholinesterue 
rnolecule. At hiiher dose levels cholinesterase inhibition will undoubtedly 
add to the action, but to what extent this is important in the facUitation ol 
neuromuscular transmission is debatable. One should only asaurne that it ls 
able to inhibit cholinesterase at hiJher dose levels V'ilich ,may not ada to its 
action. 
One cannot quantitate the s~ in tl:u.~ In.uscle sections. There is 
Uttle infonnation in the litera.ture as to now ll.iuch cholil18sterase there has 
to be present to stain. One can cOlupare 61"ossly the a.znount of staining 
between muscle sections though. and there is no doubt in the present studies 
that n.Htthoqan"4b~UlouiUlll treated j,'lj,uscle wa.s intermediate in stain1n6 belween 
edrophonium and ambenoniw.l"4. 
The efficacy of the ;llethod used in ~Jronj,ot1n6 in::.r.uediate precipitat1Gn 
is, of course. dependent upon the adequate penetra.tion of both copper thio-
choline and copper ~cinate from the surrounding L:'lediW:JJ. to the sites oi the 
e1lZTme in the tissues. The intensity of the specific stain at any site is 
dependent upon I:rla.ny 1actors. foremost OfA-J.lic.n are l>robably the concentra-
tion of the enzy.u.l.e and its reaction velocity or turnover number. The 
loca.Uzation iJf specific cholinesterase is iavored in the present technique 
by a substrate concentration (5 X 10-3 1: • .1) in the optirnal range for the 
enzyme (Augustinsson. 1948). However. nonspecific esterases can also 
~drolyr;e t..~e substrate at this concentration. although at a n1l6: h slower 
rate. In any histochemical procedure the question arises as to \vhether or 
not the area where a :)recipUate is seen repreaents the actual site of 
enzymatic action. The alternative interpretation is that dUfusion of the 
initial product of bydrolysis or of the subsequent reaction product huL ~J 
occurred. foUowed by a precipitation at an adjacent site. V( 1th the presen1 
method the possibility of diffusion prior to precipitation was m1n1mized by 
the addition of concentrated sodium sullate and a pH of 8. 1 (Koelle, 1951). 
Since the results of the present experiments do not agree with the 
classical anticholinesterase acUon of the compounds u •• d, an alternate 
theory 18 needed to explain their eftects. 
An action of acetylcholine at the autonomic ganglia, which may also 
operate at the neuromuscular junction, has been suagMted by VoUe and 
Koelle (1981) to be part of normalsyuaptic transmission. According to 
their hypothesis. the pre- sJD&PUe nerve impulse causes the release of a 
small amount of acetylcholine which then acts on the pre-synaptic nerve 
endings to cause a greater release of the sarne transmitter whieb is then 
aultlei.t to depolarize the post .. synaptic receptor. The,. have also pro-
posed that an important function of ganglionic acetylcholinesterase may be 
protection of the preganglionic term1Dations from depolarization and 
antidromic t1r1ng in response to acetylcholine liberated by themselves and 
adjaceJlt terminations. V/bether or not thia happens at the neuromuscular 
juneUon has not been shown. Hubbard, Schmidt and Yokota, (1965), have 
provided direct evidence for a depolarizing acUon of acetylcholine on nerve 
terminala. It appears that the physiological action of acetylcbo!1ne may 
provide a negative feedback on further acetylcholine release. However. 
Koelle (personal communication) is d.lcribina eventa that occur duritll one 
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action potential, where .. s Hubbard. Schmidt aDd Yokota are dbcu •• t.q the 
effect. of .ucce •• ive action potentiab on each other. Thia provide. another 
cholinoceptlve lite·lor drul action at the neuromuscular junction. A 
mechartism for neuromuscular facilitation usinl anticholln •• tera •• s would 
be inhibition of choline.tera •• aUowhll acetylcholine to work at the pre-
synaptic lite (1;ccle., Katz, Kufner, 194,,). The result. of the pre.ent 
experiment. indicate that ambenonium could work via this mecbanbm. The 
other compounds did not inhibit cholin •• tera ••• and U they facilitate tran .... 
mis.ioll via a prellynapticdte it InuIt b. thro"lh a db'ect action at the 
receptor alte. 
Karczmar. in con.ielerinl the .. CUOD. of certalD antichoUn •• teraae 
inhibitor. at the neuromyal junction. found that the mono-and bi8-quaternary 
inhibitors exhibit other action. which are not dependent on acetylcholine.ter-
a •• inhibition. There is incomplete correlation between acetylcholine.tera.e 
inhibition, acetylcholine twitch. curare antagODism, aad mUlcle twitch 
poteaUation (Karczmar, 1957). An intere.tial pheaomeaon 1n lh. fro, is 
au,mllDtation without proloD,ation of the end plate potealial or acetylcholine 
~epolarization (Karczmar. Kim, Koketlllu, 1961). The.e workers cODclude 
~hat th •• e compound. .ensiU •• the end plate. .ince they lacUitate depolarba-
~ion of the endplate without havill, a depolarbinl action 01 their own. 
Neostigmine and edrophonium po.s ••• a direct depolarisinl action 
~t the motor enciplate but thie action has been shoWll to be too weak to 
contribute to the facilitating action of these drugs on neuromuscular trans-
mission (Hobbiger, 1952; Smith, Cohen, PeUkan and Unna. 1952; Nastuk and 
Alexander" 1954). 
Many experiments in which the eftecta of thue drugs were tested on 
muscle and motor nerve action potentials led to the conclusion that they 
possess an action on the n10tor nerve endings. Twenty-six years ago it 
was shown that antidromic nerve activity occurred from the ventral roots 
of cats during the muscular contraction provoked by the intra-arterial 
~ection of acetylcholine. It was suggested as a result of these experiments 
that neostigmine inh1bited acetylcholinesterase and allowed acetylcholine to 
work on the nerve terminal (Masland and \Vigton. 1940). However, it is 
clear from the calculations of Ogston (1955), that even it not destroyed by 
choUnesterase. this acetylcholine would rapidly d1tfule away from the 
junctional region. The year followlng Maslarui's and v~' 19ton'lI work, Feng 
and L1 (1941) suggested that anticholinesterases worked directly on the nerve 
terminal. Other workers concluded that repetitive firing of the muscle 
caused the backfiring on the nerve (Eccle., Katz and Kutner, 1942). This 
latter concept was accepted until Riker, Roberta, Standaert and Fujimori 
(1957), using a compound which blocked muscle potentials, were st1ll able 
ta record antidromic phenomenon on the nerve. It has been shown that the 
whole of the swnmed muscle acUon currents are required to produce a back 
response in responsive nerve ttbers (lloyd, 1942; Brown and Matthews, 19(0) 
This is the ephaptic back res?onse initiated in SatHe n.otor fibers by the 
muscle action current. These workers have also demonstrated that when 
the muscle i8 submaximally stimulated the ephaptic potential disappears. 
Anticholinesterase compounds have been observed to cause backfiring in 
ventral roots in the presence of a submaxinlally stimulated muscle (\\ emer, 
1960). Blaber and Bow-man (1963b) have shown that the duration of the 
repetitive discharges produced by close-arterially injected edrophonium and 
neostigmine was approximately 50 rnilliseconds following each main nerve 
spike, and this corresponds closely with the duration of the negative after-
potential of the nerve terminal as recorded by Hubbard and Schmidt (1961). 
Ambenonium was observed to cause antidromic tiring for 300 mUlaeconds 
and methoxyambenonium was the only drug studied which. by itself. was 
unable to elicit antidromic activity in motor aKons (Blaber and Bowman, 
1963b). From the results of the present experiments it seems that the 
prolonged duration of repetitive firing produced by ambenoniUIrl in Blabert s 
and Bowman's experiments may well have been due to preserved acetylcholinEio 
This is not true of edrophonium and neostigmine which could act via the 
pre-synaptic mechaDiam, nor of methoxyambenonium which appears to act 
via a mechanism w ilich does not involve preservation of transmitter or the 
pre-synaptic mechanism. 
The results obtained in the present study support the view that 
facUitatory drugs act at more than one site at the neuromuscular junction. 
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All the drugs used in this work have been shown to inhibit cholinesterase 
to some extent (Blaber, 1963), all appear to have some action at the nerve 
terminal (Blaber, et a1. 1963 a, b) and some ha.ve been shown to possess 
either a curare .. Uke, depolarizing, or sensitizing action on the end-plate 
(Karczmar, 1957; Karczmar, et ai, 1961). This suggests that the receptor 
characteristics at all three sites are similar and it may be impossible to 
produce a drug which selectively combines at one site only. To produce a.ny 
one of these actions, different molecular characteristics are required which 
frequently, but not necessarily, occur in association with each other. Viewee 
in this way, we are merely measuring a degree of overlap of classes of 
agents endowed with inde?fmdently variable actions. Interaction betw'een 
different receptor sites must always occur, particularly with higher 
concentrations produced by intravenous administration, and this probably 
explains why their effects on transmission cannot be correlated with any 
single action of the drugs. Our results show that with close arterial 
injections facilitation of r.1uscle twitch results, without inhibition of cholines-
terase, which differed from intravenous administration of the compounds. 
Ambenonium was the only drug used which inhibited cholinesterase to a 
large eldent dudng c. a. injection, and it is therefore possible that the action 
of ambenonium is more dependent upon preserved acetylcholine at effector 
cells than at other sites w here the drug has actions. 
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